Viewing StudyNCT05712096



Ignite Creation Date: 2024-05-06 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 2:50 PM
Study NCT ID: NCT05712096
Status: COMPLETED
Last Update Posted: 2023-07-27
First Post: 2023-01-26

Brief Title: eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
COVID-19
SARS-CoV-2
Keywords:
Name View
Evusheld View
SARS-CoV-2 View
COVID-19 View
Immunocompromised Patients View
Pre-exposure Prophylaxis Against COVID-19 View